Study results of psilocybin treatment in bipolar II depression published in JAMA Psychiatry Psychedelics Investing
Thermo Fisher Scientific Establishes 2030 Renewable Electricity Goal and Solar Power Purchase Agreement with ib vogt Medical Device Investing
Novartis receives FDA approval for Fabhalta® , offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH Life Science Investing
Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation Awareness Day Pharmaceutical Investing
Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot Geography
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink Medical Device Investing
